Page 4 - ஸ்காட்டிஷ் ஹண்டிங்டன் சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aberdeen first in UK to recruit for new Huntington’s disease trial Updated: 03/04/2021, 9:27 am © Shutterstock / Tashatuvango Aberdeen has recruited the first UK patient for a new Huntington’s disease trial Aberdeen University has recruited the first UK patient for a new trial investigating a drug for the treatment of Huntington’s disease. Also known as HD, Huntington’s disease is an inherited condition that causes neurons in the brain to degenerate. The condition can get gradually worse over time there is currently no effective treatment to halt or slow its progression. The PROOF-HD study, sponsored by Prilenia Therapeutics, will enrol up to 480 people with early-stage Huntington’s at approximately 60 sites across the US, Canada and Europe.

United kingdomShutterstock tashatuvangoZosia miedzybrodzkaAberdeen universityScottish huntington associationUniversity of aberde professor zosia miedzybrodzkaPrilenia therapeuticsProfessor zosiaScottish huntingtonProfessor miedzybrodzkaஒன்றுபட்டது கிஂக்டம்குட்டைநாய் வகை பல்கலைக்கழகம்ஸ்காட்டிஷ் ஹண்டிங்டன் சங்கம்ஸ்காட்டிஷ் ஹண்டிங்டன்